Construction of emissive ruthenium(II) metallacycle over 1000 nm wavelength for in vivo biomedical applications

Although Ru(II)-based agents are expected to be promising candidates for substituting Pt-drug, their in vivo biomedical applications are still limited by the short excitation/emission wavelengths and unsatisfactory therapeutic efficiency. Herein, we rationally design a Ru(II) metallacycle with excit...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuling, Li, Chonglu, Lu, Shuai, Wang, Zhizheng, Liu, Shuang, Yu, Xiujun, Li, Xiaopeng, Sun, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010459/
https://www.ncbi.nlm.nih.gov/pubmed/35422104
http://dx.doi.org/10.1038/s41467-022-29572-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010459/
https://www.ncbi.nlm.nih.gov/pubmed/35422104
http://dx.doi.org/10.1038/s41467-022-29572-2

Ejemplares similares